Backed by market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, wider supply chain intelligence, emerging startup coverage, and detailed product-level insights, The Business Research Company’s 2026 market reports are designed to offer research that is more actionable and strategically valuable than ever.
Hydroxychloroquine Market Value Analysis: What Growth Lies Ahead Over The Forecast Period?
The hydroxychloroquine market size has shown strong expansion in recent years. It is projected to grow from $2.38 billion in 2025 to $2.52 billion in 2026, achieving a compound annual growth rate (CAGR) of 6.2%. The growth observed in the historic period stems from factors such as the high prevalence of malaria in endemic regions, its well-established use in autoimmune disorders, increasing awareness regarding hydroxychloroquine benefits, its availability through hospital and retail pharmacies, and the growing clinical adoption for rheumatoid arthritis and lupus.
The hydroxychloroquine market is anticipated to experience significant expansion over the next few years. It is projected to achieve a value of $3.26 billion by 2030, registering a compound annual growth rate (CAGR) of 6.6%. This growth during the forecast period is attributed to ongoing research into COVID-19 applications, the development of new formulations and delivery methods, the expansion of online pharmacy channels, increasing government health initiatives for malaria prevention, and rising investments in clinical trials and off-label studies. Noteworthy trends for the forecast duration include the increasing use of hydroxychloroquine for malaria prevention and treatment, greater adoption in the management of rheumatoid arthritis and lupus, an increase in off-label uses and clinical research for COVID-19, the proliferation of tablet formulations and injectable variants, and enhanced distribution through hospital, online, and retail pharmacies.
Get A Free Sample Report With In-Depth Market Insights:
Hydroxychloroquine Market Growth Momentum: What Factors Are Shaping Demand?
The increasing instances of rheumatoid arthritis are anticipated to stimulate the expansion of the hydroxychloroquine market in the future. Rheumatoid arthritis is an autoimmune and inflammatory illness where the immune system mistakenly attacks healthy cells, causing inflammation in the affected bodily regions. Hydroxychloroquine proves beneficial for treating rheumatoid arthritis as it helps mitigate inflammation and relieve symptoms, thereby enhancing the overall quality of life for numerous patients. For example, data from June 2023, provided by the Centers for Disease Control and Prevention, a US-based health protection agency, indicated that 54.4 million adults in the United States had been diagnosed with arthritis, a figure projected to climb to 78 million by the year 2040. Consequently, the rising prevalence of rheumatoid arthritis is expected to propel the hydroxychloroquine market.
Hydroxychloroquine Market Driver: Impact Of Rising Healthcare Expenditure On The Growth Of The Hydroxychloroquine Market
The increasing spending on healthcare is anticipated to drive the expansion of the hydroxychloroquine market moving forward. Healthcare expenditure represents the total financial resources a country, organization, or individual allocates to health-related services and products. This rise in healthcare spending is influenced by factors such as an aging population, the prevalence of chronic illnesses, advancements in medical technology, and heightened consumer expectations for quality care. Hydroxychloroquine has the potential to mitigate increasing healthcare costs by offering an affordable treatment alternative for various conditions, thereby reducing the dependency on more expensive medical interventions. For instance, in November 2023, the Canadian Institute for Health Information, a Canada-based non-profit organization, projected total health expenditure to reach $344 billion in 2023, indicating a modest growth of 2.8% compared to the prior year. Consequently, the escalating healthcare expenditure is fostering growth in the hydroxychloroquine market.
Hydroxychloroquine Market Segment Breakdown: Which Categories Lead On Revenue?
The hydroxychloroquine market covered in this report is segmented –
1) By Drug Activity: Anti-Malarial Drug, Anti-Rheumatic Drug, Lupus Suppressant Drug, Anti COVID-19 Drug, Other Drug Activity
2) By Formulation: Tablets, Injection
3) By Application: Malaria, Rheumatoid Arthritis, Lupus Erythematosus, COVID-19, Other Applications
4) By Distribution Channel: Hospital Pharmacy, Online Pharmacy, Specialty Drug Stores, Retail Pharmacy
Subsegments:
1) By Anti-Malarial Drug: Treatment Of Malaria, Prophylaxis For Malaria
2) By Anti-Rheumatic Drug: Treatment Of Rheumatoid Arthritis, Treatment Of Juvenile Idiopathic Arthritis
3) By Lupus Suppressant Drug: Treatment Of Systemic Lupus Erythematosus
4) By Anti COVID-19 Drug: Treatment Of COVID-19 Symptoms
5) By Other Drug Activity: Treatment Of Other Autoimmune Disorders, Additional Off-label uses
Hydroxychloroquine Market Leading Players And Competitive Positioning
Major companies operating in the hydroxychloroquine market are Bayer AG, Dr. Reddy’s Laboratories Ltd., Zydus Group, Ipca Laboratories Ltd., Wallace Pharma, Teva Pharmaceuticals Inc., Mylan Pharmaceuticals Inc., Novartis AG, Intas Pharmaceuticals Ltd., Lupin Limited, Shanghai Zhongxi Sanwei Pharmaceutical Co. Ltd., Torrent Pharmaceuticals Ltd., Hikma Pharmaceuticals plc, Sandoz International GmbH, Cipla Limited, Shenhua Pharmaceutical Co. Ltd., Sanofi S.A., Macleod Pharmaceuticals Ltd., Laurus Labs, TAJ Pharmaceuticals, Wuhan Wuyao Pharmaceutical Co. Ltd., Concordia Healthcare, Pfizer Inc., Cadila Pharmaceuticals, Hetero Drugs Ltd., Jubilant Generics Limited, Alembic Pharmaceuticals Limited, Sun Pharmaceutical Industries Ltd., Aurobindo Pharma USA Inc., Alkem Laboratories Ltd., Glenmark Pharmaceuticals Ltd., Unichem Laboratories Ltd., Wockhardt Limited, Emcure Pharmaceuticals Ltd., Strides Pharma Science Ltd., Indoco Remedies Ltd.
View The Full Hydroxychloroquine Market Report:
Hydroxychloroquine Market Regional Split: Which Areas Are Fueling Growth?
North America was the largest region in the hydroxychloroquine market in 2025. Middle East is expected to be the fastest-growing region in the hydroxychloroquine market report. The regions covered in the hydroxychloroquine market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
